AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE Drug Patent Profile

When do Amlodipine Besylate And Benazepril Hydrochloride patents expire, and what generic alternatives are available?

Amlodipine Besylate And Benazepril Hydrochloride is a drug marketed by Apotex, Aurobindo Pharma Ltd, Cipla, Dr Reddys Labs Inc, Lupin Pharms, Mylan, Strides Pharma, Teva Pharms, Watson Labs, and Watson Labs Inc. and is included in twelve NDAs.

The generic ingredient in AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE is amlodipine besylate; benazepril hydrochloride. There are fifty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the amlodipine besylate; benazepril hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Amlodipine Besylate And Benazepril Hydrochloride

A generic version of AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE was approved as amlodipine besylate; benazepril hydrochloride by LUPIN PHARMS on February 5^th, 2010.

Summary for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

US Patents:	0
Applicants:	10
NDAs:	12
Finished Product Suppliers / Packagers:	14
Raw Ingredient (Bulk) Api Vendors:	2
Clinical Trials:	6
Patent Applications:	12
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE?	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE excipients list
DailyMed Link:	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE at DailyMed

Recent Clinical Trials for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Shanghai Jiao Tong University School of Medicine	Phase 4
Novartis Pharmaceuticals	Phase 4
Dr. Reddy's Laboratories Limited	Phase 1

See all AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE clinical trials

Pharmacology for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Drug Class	Angiotensin Converting Enzyme Inhibitor Calcium Channel Blocker Dihydropyridine Calcium Channel Blocker
Mechanism of Action	Angiotensin-converting Enzyme Inhibitors Calcium Channel Antagonists Cytochrome P450 3A Inhibitors
Physiological Effect	Decreased Blood Pressure

Anatomical Therapeutic Chemical (ATC) Classes for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

C08CA	Dihydropyridine derivatives
C08C	SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
C08	CALCIUM CHANNEL BLOCKERS
C	Cardiovascular system

C09AA	ACE inhibitors, plain
C09A	ACE INHIBITORS, PLAIN
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C	Cardiovascular system

US Patents and Regulatory Information for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Pharms	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	077179-001	May 18, 2007		DISCN	No	No
Mylan	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	079047-001	Jul 5, 2011		DISCN	No	No
Watson Labs	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	077890-003	Oct 14, 2010	AB	RX	No	No
Teva Pharms	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	077179-004	May 18, 2007		DISCN	No	No
Watson Labs	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	077890-004	Oct 14, 2010	AB	RX	No	No
Lupin Pharms	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	078466-006	Jul 5, 2011	AB	RX	No	No